Cover Image

The associations of supervised consumption services with the rates of opioid‐related mortality and morbidity outcomes at the public health unit level in Ontario (Canada): A controlled interrupted time‐series analysis

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Tessa Robinson, Forough Farrokhyar, Benedikt Fischer
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Drug and Alcohol Review
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Trends in alcohol‐attributable morbidity and mortality in Germany from 2000 to 2021: A modelling study
by: Ludwig Kraus, et al.
Published: (2024)

Characterising methamphetamine/amphetamine use among opioid agonist therapy‐seeking adults with prescription‐type opioid use disorder in Canada
by: Jenna Langlois, et al.
Published: (2024)

Changes in the Sex/Gender Gap in Cannabis Use in Ontario, Canada From 2001 to 2019
by: Justin Matheson, et al.
Published: (2025)

What drove changes in alcohol sales during the COVID‐19 pandemic in Czechia? An interrupted time series analyses
by: Benjamin Petruželka, et al.
Published: (2025)

Is there a link between per capita alcohol consumption and cancer mortality?
by: Iman Dadgar, et al.
Published: (2024)

Trends in toxicological findings in unintentional opioid or stimulant toxicity deaths in Québec, Canada, 2012–2021: Has Québec entered a new era of drug‐related deaths?
by: Uyen Do, et al.
Published: (2024)

Alcohol consumption and mortality among Canadian drinkers: A national population‐based survival analysis (2000–2017)
by: James M. Clay, et al.
Published: (2024)

More data on opioid diversion is needed
by: Leonora Regenstreif, et al.
Published: (2024)

Stigma, and factors associated with experiencing stigma, while visiting health‐care services among samples of people who use illegal drugs in Australia
by: Rachel Sutherland, et al.
Published: (2024)

It is not just opioids!
by: Robert Kent
Published: (2025)

Rotation from methadone to buprenorphine using a micro‐dosing regime in patients with opioid use disorder and serious mental illness: A case series
by: Vivian C. Praeger, et al.
Published: (2024)

Perceptions of clinicians on promoting oral health care in an alcohol and other drug use health care service: A qualitative study
by: Agnivo Sengupta, et al.
Published: (2025)

Changing patterns of opioid agonist therapy prescribing in a network of specialised clinics providing care to people with opioid use disorder in Victoria, Australia, 2015 to 2023
by: Joshua Dawe, et al.
Published: (2025)

The reflections of health service providers on implementing contingency management for methamphetamine use disorder in Australia
by: Simon Clay, et al.
Published: (2024)

Health utility among people who regularly use opioids in Australia
by: Anh Dam Tran, et al.
Published: (2024)

Provider costs of treating opioid dependence with extended‐release buprenorphine in Australia
by: Stella Settumba, et al.
Published: (2024)

Treatment satisfaction and patient reported outcomes among people with opioid use disorder participating in an open‐label, non‐randomised trial of long‐acting injectable buprenorphine treatment in Australian custodial settings
by: Bethany White, et al.
Published: (2025)

Diverting attention away from novel approaches to preventing opioid overdose deaths
by: Carol Strike, et al.
Published: (2024)

Patterns of opioid prescribing to opioid‐naive patients after surgical and emergency care: A population‐based cross‐sectional study using linked administrative databases in Nova Scotia (2017–2019)
by: Roah A. Merdad, et al.
Published: (2025)

The impact of Scotland's minimum unit pricing for alcohol policy on people accessing services for alcohol dependence: A difference‐in‐difference structured interview study
by: Penny Buykx, et al.
Published: (2024)

Early response to H.R. 1: SUD field united in ways to continue services
by: Alison Knopf
Published: (2025)

Policies for recovery from drug use: Differences between public stigma and perceived stigma and associated factors
by: Tingyu Luo, et al.
Published: (2024)

Trends in novel opioid use and detections in exposures and police drug seizures in New South Wales
by: Janette L. Smith, et al.
Published: (2025)

AMA supports new FDA labeling on opioids
by: Alison Knopf
Published: (2025)

Nalmefene auto‐injector approved for opioid overdose
by: Alison Knopf
Published: (2024)

The truth about NYS's opioid settlement fund
by: Rob Kent
Published: (2025)

Stigma by association among alcohol and other drug and harm reduction workers: Implications for workplace outcomes
by: Loren Brener, et al.
Published: (2024)

SAMHSA requests public comment on ICCPUD alcohol intake and health study
by: Alison Knopf
Published: (2024)

Relationship between patient activation and utilisation of health care and harm reduction services among people who inject drugs in Baltimore, Maryland
by: Pieter Baker, et al.
Published: (2024)

JAMA Viewpoint argues for better use of opioid funds
by: Alison Knopf
Published: (2026)

Current wave of opioid crisis run by fentanyl combinations
by: Gary Enos
Published: (2024)

Pharmacists did not reduce opioid or benzodiazepine use or falls
by: Alison Knopf
Published: (2026)

New South Wales alcohol and other drug service providers' perceptions of the relative importance of client variables for determining treatment need
by: Briony Larance, et al.
Published: (2024)

What influences Australian pharmacists' decisions to supply opioids? Results from a survey and randomised controlled factorial experiment
by: Louisa Picco, et al.
Published: (2025)

ASAM convenes in D.C. to discuss opioid crisis with lawmakers
by: Alison Knopf
Published: (2024)

VHA study: Warn veterans of suicide risks of opioids and guns
by: Alison Knopf
Published: (2025)

Uses of opioid settlement funds emphasize integral role of EMS
by: Gary Enos
Published: (2026)

Changes in Australians' attitudes towards supervised injecting facilities
by: Zachary Lloyd, et al.
Published: (2024)

The market matters: Shifting the minimum unit price
by: Nicholas Taylor, et al.
Published: (2024)

NY methadone clinics fight for anti‐stigma opioid settlement funds
by: Alison Knopf
Published: (2025)